Cardio-COVID Disease: Current Updates and Perspectives
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".
Deadline for manuscript submissions: 29 May 2024 | Viewed by 112
Special Issue Editor
Interests: interventional cardiology; drug-eluting stents; hypertension; aortic valve; coronary artery disease
Special Issue Information
Dear Colleagues,
In recent years, SARS-CoV-2 has been an unfortunate fixture in our clinical, scientific, and personal lives. The COVID-19 pandemic struck fast and hard but, after the first period of shock and confusion, the scientific community found novel ways to collaborate and obtain knowledge about the disease, its consequences, and possible treatments. Now that the pandemic wave has reached a plateau, and vaccines have led to a flattening in the mortality rate, it is time to move into a new phase and address the challenges of managing the long-term sequelae of COVID-19.
As well as the lungs, we know that the cardiovascular system is often impacted by the disease (so-called “cardio-COVID disease”), via a combination of direct infection, thrombosis, and hyperimmune reactions, leading to vasculitis and myocarditis. Additionally, COVID-19 may exacerbate pre-existing cardiovascular conditions.
Huge numbers of raw data were generated at the most intense stage of the pandemic period. Now, it is time to organize these data and take further steps. There is an urgent need for high-level research to allow us to understand the disease, its associated protective or risk factors, and possible therapeutic strategies, as the long-term impact on our patients will be significant.
This Special Issue aims to collect the available research in this field in order to gather valuable insights into the pathogenesis, prognostic implications, and possible therapeutic mechanisms regarding cardio-COVID. We welcome contributions of original research articles and reviews.
Dr. Dario Pellegrini
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cardio-COVID disease
- cardiovascular complications
- myocardial damage
- cardiovascular events
- COVID-19
